Cronkhite-Canada Syndrome: A Case Report and Literature Review of Gastrointestinal Polyposis Syndrome (Short Report)


Cronkhite-Canada syndrome (CCS) is a rare, non-inherited polyposis syndrome, characterized by diffuse gastrointestinal (GI) hamartomatous polyposis with unique dermatologic changes including alopecia, skin hyperpigmentation, and nail dystrophy. Patients can typically present with diarrhea, weight loss, protein-losing enteropathy, and nutritional deficiency. However, it can demonstrate diverse other clinical features, usually with poor prognosis. Currently, there are no specific diagnostic criteria established yet. The etiology of CCS is still obscure, but an autoimmune process has been suggested. Here we present an 81-year-old Caucasian female who had clinical presentations, physical exam, imaging, endoscopy and pathology findings that were all consistent with the diagnosis of CCS. We also include a detailed literature review of the other gastrointestinal polyposis syndromes (hamartomatous, adenomatous, hyperplastic and inflammatory polyposis). A high index of suspicion and recognition of the characteristic clinical, endoscopic as well as histopathological findings of CCS, as well as different gastrointestinal polyposis conditions, can help clinicians with more timely and correct diagnosis.

Share and Cite:

Shen, X. , Husson, M. and Lipshutz, W. (2014) Cronkhite-Canada Syndrome: A Case Report and Literature Review of Gastrointestinal Polyposis Syndrome. Case Reports in Clinical Medicine, 3, 650-659. doi: 10.4236/crcm.2014.312138.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Cronkhite, L.W. and Canada, W.J. (1955) Generalized Gastrointestinal Polyposis; an Unusual Syndrome of Polyposis, Pigmentation, Alopecia and Onychotropia. The New England Journal of Medicine, 252, 1011-1015.
[2] Ward, E.M. and Wolfsen, H.C. (2002) Review Article: The Non-Inherited Gastrointestinal Polyposis Syndromes. Alimentary Pharmacology Therapeutics, 16, 333-342.
[3] Daniel, E.S., Ludwig, S.L., Lewin, K.J., Ruprecht, R.M., Rajacich, G.M. and Schwabe, A.D. (1982) The Cronkhite-Canada Syndrome: An Analysis of Clinical and Pathologic Features and Therapy in 55 Patients. Medicine, 61, 293-309.
[4] Goto, A. (1995) Cronkhite-Canada Syndrome: Epidemiological Study of 110 Cases Reported in Japan. GekaHokan, 64, 3-14.
[5] Sweetser, S., Ahlquist, D.A., Osborn, N.K., Sanderson, S.O., Smyrk, T.C., Chari, S.T. and Boardman, L.A. (2012) Clinicopathologic Features and Treatment Outcomes in Cronkhite-Canada Syndrome: Support for Autoimmunity. Digestive Diseases and Sciences, 57, 496-502.
[6] Riegert-Johnson, D.L., Osborn, N., Smyrk, T. and Boardman, L.A. (2007) Cronkhite-Canada Syndrome Hamartomatous Polyps Are Infiltrated with IgG4 Plasma Cells. Digestion, 75, 96-97.
[7] Takeuchi, Y., Yoshikawa, M., Tsukamoto, N., Shiroi, A., Hoshida, Y., Enomoto, Y., Kimura, T. and Fukui, H. (2003) Cronkhite-Canada Syndrome with Colon Cancer, Portal Thrombosis, High Titer of Anti-Nuclearantibodies, and Membranous Glomerulonephritis. Journal of Gastroenterology, 38, 791-795.
[8] Patil, V., Patil, L.S., Jakareddy, R., Verma, A. and Gupta, A.B. (2013) Cronkhite-Canada Syndrome: A Report of Two Familial Cases. Indian Journal of Gastroenterology, 32, 119-122.
[9] Kato, K., Ishii, Y., Mazaki, T., Uehara, T., Nakamura, H. and Tanaka, M. (2013) Spontaneous Regression of Polyposis Following Abdominal Colectomy and Helicobacter pylori Eradication for Cronkhite-Canada Sydrome. Case Reports in Gastroenterology, 7, 140-146.
[10] Okamoto, K., Isomoto, H., Shikuwa, S., Nishiyama, H., Ito, M. and Kohno, S. (2008) A Case of Cronkhite-Canada Syndrome: Remission after Treatment with Anti-Helicobacter pylori Regimen. Digestion, 78, 82-87.
[11] Isobe, T., Kobayashi, T., Hashimoto, K., Kizaki, J., Miyagi, M., Aoyagi, K., Koufuji, K. and Shirouzu, K. (2013) Cronkhite-Canada Syndrome Complicated with Multiple Gastric Cancers and Multiple Colon Adenomas. American Journal of Case Reports, 14, 120-128.
[12] Jain, A., Nanda, S., Chakraborty, P., Kundra, A., Anuradha, S., Reddy, B.S. and Kar, P. (2003) Cronkhite-Canada Syndrome with Adenomatous and Carcinomatous Transformation of Colonic Polyp. Indian Journal of Gastroenterology, 22, 189-190.
[13] Malhotra, R. and Sheffield, A. (1988) Cronkhite-Canada Syndrome Associated with Colon Carcinoma and Adenomatous Changes in C-C Polyps. The American Journal of Gastroenterology, 83, 772-776.
[14] Nagata, J., Kijima, H., Hasumi, K., Suzuki, T., Shirai, T. and Mine, T. (2003) Adenocarcinoma and Multiple Adenomas of the Large Intestine, Associated with Cronkhite-Canada Syndrome. Digestive and Liver Disease, 35, 434-438.
[15] Ward, E.M. and Wolfsen, H.C. (2003) Pharmacological Management of Cronkhite-Canada Syndrome. Expert Opinion on Pharmacotherapy, 4, 385-389.
[16] Aretz, S. (2010) The Differential Diagnosis and Surveillance of Hereditary Gastrointestinal Polyposis Syndromes. Deutsches Arzteblatt International, 107, 163-173.
[17] Seshadri, D., Karagiorgos, N. and Hyser, M.J. (2012) A Case of Cronkhite-Canada Syndrome and a Review of Gastrointestinal Polyposis Syndromes. Gastroenterology & Hepatology, 8, 197-201.
[18] Shah, N.B. and Lindor, N.M. (2010) Lower Gastrointestinal Tract Cancer Predisposition Syndromes. Hematology/ Oncology Clinics of North America, 24, 1229-1252.
[19] Kastrinos, F. and Syngal, S. (2011) Inherited Colorectal Cancer Syndrome. Cancer Journal, 17, 405-415.
[20] Brosens, L.A., Langeveld, D., van Hattem, W.A., Giardiello, F.M. and Offerhaus, G.J. (2011) Juvenile Polyposis Syndrome. World Journal of Gastroenterology, 17, 4839-4844.
[21] Zbuk, K.M. and Eng, C. (2007) Hamartomatous Polyposis Syndrome. Nature Clinical Practice. Gastroenterology & Hepatology, 4, 492-502.
[22] Howe, J.R., Mitros, F.A. and Summers, R.W. (1998) The Risk of Gastrointestinal Carcinoma in Familial Juvenile Polyposis. Annals of Surgical Oncology, 5, 751-756.
[23] Calva, D. and Howe, J.R. (2008) Hamartomatous Polyposis Syndrome. Surgical Clinics of North America, 88, 779-817.
[24] Brosens, L.A., van Hattem, A., Hylind, L.M., Iacobuzio-Donahue, C., Romans, K.E., Axilbund, J., Giardiello, F.M., et al. (2007) Risk of Colorectal Cancer in Juvenile Polyposis. Gut, 56, 965-967.
[25] Gammon, A., Jasperson, K., Kohlmann, W. and Burt, R.W. (2009) Hamartomatous Polyposis Syndromes. Best Practice & Research Clinical Gastroenterology, 23, 219-231.
[26] Jass, J.R. (2008) Colorectal Polyposes: From Phenotype to Diagnosis. Pathology-Research and Practice, 204, 431-447.
[27] Schreibman, I.R., Baker, M., Amos, C. and McGarrity, T.J. (2005) The Hamartomatous Polyposis Syndromes: A Clinical and Molecular Review. The American Journal of Gastroenterology, 100, 476-490.
[28] Bülow, S., Björk, J., Christensen, I.J., Fausa, O., Järvinen, H., Moesgaard, F. and Vasen, H.F.A., DAF Study Group (2004) Duodenal Adenomatosis in Familial Adenomatous Polyposis. Gut, 53, 381-386.
[29] Omundsen, M. and Lam, F.F. (2012) The Other Colonic Polyposis Syndromes. ANZ Journal of Surgery, 82, 675-681.
[30] Wynter, C.V., Walsh, M.D., Higuchi, T., Leggett, B.A., Young, J. and Jass, J.R. (2004) Methylation Patterns Define Two Types of Hyperplastic Polyp Associated with Colorectal Cancer. Gut, 53, 573-580.
[31] Jass, J.R. (2004) Hyperplastic Polyps and Colorectal Cancer: Is There a Link? Clinical Gastroenterology and Hepatology, 2, 1-8.
[32] Ng, K.H., Mathur, P., Kumarasinghe, M.P., Eu, K.W. and Seow-Choen, F. (2004) Cap Polyposis: Further Experience and Review. Diseases of the Colon & Rectum, 47, 1208-1215.
[33] Petris, G.D., Dhungel, B.M., Chen, L. and Pasha, S.F. (2013) Inflammatory “Cap” Polyposis: A Case Report of a Rare Nonneoplastic Colonic Polyposis. International Journal of Surgical Pathology, 22, 378-382.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.